Skip to main content

Table 2 Toceranib dosing groups

From: Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose

Dose range (mg/kg)

2.35-2.39

2.40-2.49

2.50-2.59

2.60-2.69

2.70-2.79

2.80-2.89

2.35

2.40

2.50

2.62

2.70

2.89

2.38

2.41

2.50

2.62

2.70

 

2.39

2.47

2.50

2.63

2.72

 
 

2.47

2.51

2.63

2.72

 
  

2.51

2.66

2.73

 
  

2.51

2.68

2.75

 
  

2.53

2.68

2.78

 
  

2.54

2.68

2.78

 
  

2.55

2.69

  
  

2.56

   
  

2.57

   
  

2.57

   
  

2.58

   
  

2.59

   
  

2.59

   
Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us